Articles

  • Jun 13, 2024 | wsj.com | Jessica Mendoza |Matt Kwong |Peter Loftus

    In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly LLY -0.62%decrease; red down pointing triangle, was on a West Coast college tour with his daughter when his phone rang. A deputy was calling with good news: The company’s new, experimental drug tirzepatide not only cut blood-sugar levels in people with diabetes in a small clinical trial, it also helped them lose much more weight than prior weight-loss drugs could achieve.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
3K
Tweets
9K
DMs Open
Yes
Matt Kwong
Matt Kwong @matt_kwong
4 Feb 25

RT @Ryan_Knutson: 100 million streams on Spotify!! Way to go everyone! @kate_linebaugh @_jessicamendoza @parahslatt @ardzes @annieminoff @B…

Matt Kwong
Matt Kwong @matt_kwong
3 Feb 25

RT @JustinTrudeau: I just had a good call with President Trump. Canada is implementing our $1.3 billion border plan — reinforcing the borde…

Matt Kwong
Matt Kwong @matt_kwong
3 Feb 25

RT @Alex_Panetta: An observation here as someone whose life kinda straddles both sides of the 🇨🇦 🇺🇸 border. In the U.S. the tariffs are l…